First Trust Multi-Manager Small Cap Opportunities ETF
MMSC - ETF AI Analysis
Top Page
First Trust Multi-Manager Small Cap Opportunities ETF (MMSC)
MMSC, the First Trust Multi-Manager Small Cap Opportunities ETF, has a solid but not top-tier rating, reflecting a mix of promising growth stories and meaningful risks among its small-cap holdings. Strong contributors like FirstCash and Ollie’s Bargain Outlet support the fund’s quality through solid financial performance and positive business momentum, while weaker names such as Spyre Therapeutics and Varonis Systems, with profitability and cash flow challenges, weigh on the overall picture. The main risk factor is the fund’s exposure to smaller, often unprofitable companies in areas like biotechnology, which can make performance more volatile and sensitive to financial and valuation pressures.
MMSC vs. SPDR S&P 500 ETF (SPY)
- AUM
- 51.36M
- Region
- North America
- Expense Ratio
- 0.95%
- Beta
- 1.18
- Issuer
- First Trust
- Inception Date
- Oct 13, 2021
- Dividend Yield
- 0.33%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
MMSC Summary
The First Trust Multi-Manager Small Cap Opportunities ETF (MMSC) focuses on smaller U.S. companies with a growth theme, rather than tracking a specific index. It invests across sectors like health care, technology, and industrials, aiming to find up-and-coming businesses that could become tomorrow’s leaders. Some of its better-known holdings include JFrog and Guardant Health. Investors might consider MMSC if they want diversification into small, fast-growing companies managed by several professional teams. A key risk is that small-cap stocks can be more volatile than larger, established companies, so the fund’s value can move up and down sharply with the market.
How much will it cost me?
This ETF has an annual expense ratio of 0.95%, which means you’ll pay about $9.50 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed by multiple professional managers who research and select small-cap growth stocks rather than simply tracking an index.
What would affect this ETF?
This ETF focuses on U.S. small-cap growth stocks in areas like health care and technology, so it could benefit if the U.S. economy stays strong, innovation spending rises, and investors become more willing to take risk on smaller companies. On the negative side, higher interest rates, economic slowdowns, or tighter regulations on health care and tech could hurt these smaller, more volatile businesses and weigh on top holdings such as Guardant Health, JFrog, and other growth names.
MMSC Top 10 Holdings
MMSC is leaning hard into U.S. small-cap growth, with a clear tilt toward health care and tech names that can move quickly in either direction. Twist Bioscience and Guardant Health have been rising over the past few months, acting like turbochargers for the fund’s performance, while Travere Therapeutics has been lagging and occasionally pulling on the brakes. On the tech side, JFrog and Zeta Global have shown steady to strong momentum, helping offset mixed showings from security players like Netskope. Overall, it’s a concentrated bet on emerging U.S. innovators.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Xometry | 2.02% | $1.03M | $6.89B | 101.98% | 55Neutral | |
| JFrog | 1.91% | $975.71K | $14.16B | 90.67% | 73Outperform | |
| Zeta Global Holdings Corp | 1.75% | $892.17K | $9.36B | 98.00% | 67Neutral | |
| Ollie's Bargain Outlet Holding | 1.51% | $770.11K | $5.63B | -24.98% | 73Outperform | |
| Netskope, Inc. | 1.39% | $711.73K | $8.89B | 9.35% | 47Neutral | |
| Varonis Systems | 1.33% | $681.20K | $5.64B | 42.60% | 48Neutral | |
| Travere Therapeutics | 1.30% | $663.06K | $4.86B | 49.45% | 56Neutral | |
| SailPoint, Inc. | 1.31% | $668.05K | $11.87B | 8.34% | 39Underperform | |
| Guardant Health | 1.25% | $638.96K | $20.52B | 61.16% | 61Neutral |
MMSC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MMSC, the sentiment is Negative. The current price of 26.19 is below the 20-day moving average (MA) of 26.24, below the 50-day MA of 26.59, and below the 200-day MA of 26.76, indicating a bearish trend. The MACD of -0.08 indicates Negative momentum. The RSI at 48.24 is Neutral, neither overbought nor oversold. The STOCH value of 74.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MMSC.
MMSC Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $26.19 | $27.00(3.10% Upside) | $51.36M | 0.95% | 63Neutral | |
| $45.91 | $62.65(36.45% Upside) | $52.99M | 0.49% | 64Neutral | |
| $34.54 | $43.40(25.67% Upside) | $51.66M | 0.85% | 63Neutral | |
| $24.67 | $35.03(42.02% Upside) | $27.93M | 0.80% | 60Neutral | |
| $25.77 | $35.62(38.23% Upside) | $7.78M | 0.28% | 62Neutral | |
| $22.05 | $26.56(20.44% Upside) | $6.86M | 0.55% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 26.19 | 3.60 | 15.94% | |
| ACSG | American Century Small Cap Growth Insights ETF | 45.91 | 7.10 | 18.28% | |
| TMFS | Motley Fool Small-Cap Growth ETF | 34.54 | 1.81 | 5.52% | |
| SGRW | Harbor Active Small Cap Growth ETF | 24.67 | 4.37 | 21.55% | |
| FSEG | Fidelity Enhanced Small Cap Growth ETF | 25.77 | 0.54 | 2.14% | |
| SAWS | AAM Sawgrass US Small Cap Quality Growth ETF | 22.05 | 1.95 | 9.70% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
